Gut to lung translocation and antibiotic mediated selection shape the dynamics of Pseudomonas aeruginosa in an ICU patient

Rachel M. Wheatley, Julio Diaz Caballero, Thomas E. van der Schalk, Fien H.R. De Winter, Liam P. Shaw, Natalia Kapel, Claudia Recanatini, Leen Timbermont, Jan Kluytmans, Mark Esser, Alicia Lacoma, Cristina Prat-Aymerich, Antonio Oliver, Samir Kumar-Singh, Surbhi Malhotra-Kumar, R. Craig MacLean*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

11 Downloads (Pure)

Abstract

Bacteria have the potential to translocate between sites in the human body, but the dynamics and consequences of within-host bacterial migration remain poorly understood. Here we investigate the link between gut and lung Pseudomonas aeruginosa populations in an intensively sampled ICU patient using a combination of genomics, isolate phenotyping, host immunity profiling, and clinical data. Crucially, we show that lung colonization in the ICU was driven by the translocation of P. aeruginosa from the gut. Meropenem treatment for a suspected urinary tract infection selected for elevated resistance in both the gut and lung. However, resistance was driven by parallel evolution in the gut and lung coupled with organ specific selective pressures, and translocation had only a minor impact on AMR. These findings suggest that reducing intestinal colonization of Pseudomonas may be an effective way to prevent lung infections in critically ill patients.

Original languageEnglish
Article number6523
JournalNature Communications
Volume13
DOIs
Publication statusPublished - 22 Nov 2022

Keywords

  • Humans
  • Pseudomonas aeruginosa/genetics
  • Anti-Bacterial Agents/pharmacology
  • Meropenem/pharmacology
  • Lung
  • Bacteria
  • Intensive Care Units

Fingerprint

Dive into the research topics of 'Gut to lung translocation and antibiotic mediated selection shape the dynamics of Pseudomonas aeruginosa in an ICU patient'. Together they form a unique fingerprint.

Cite this